TrialNeoplasia (New York, N.Y.)2020

High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study.

Eva-Maria Talvitie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.